Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
27 November 2021 - 5:32AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE
ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE
ACT OF 1934
For the month
of November 2021
Commission File Number:
001-39137
AnPac Bio-Medical Science
Co., Ltd.
(Registrant’s name)
801 Bixing Street,
Bihu County
Lishui, Zhejiang Province
323006
The People’s
Republic of China
(Address of principal
executive office)
Indicate by check mark whether the
registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F x
Form 40-F ¨
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (1): ¨
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (7): ¨
Explanatory Note:
The
Registrant is filing this Report on Form 6-K to report its quarterly financial results ended September 30, 2021 and to discuss
its recent corporate developments, which are all included into a press release dated November 26, 2021.
Attached
as exhibit to this Report on Form 6-K is the press release dated November 26, 2021.
Exhibit Index:
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
|
AnPac Bio-Medical Science Co., Ltd.
|
|
|
(Registrant)
|
|
|
|
Date: November 26, 2021
|
By:
|
/s/ Chris Chang Yu
|
|
Name:
|
Dr. Chris Chang Yu
|
|
Title:
|
Chairman of the Board of Directors and Chief Executive Officer
|
AnPac Bio Medical Science (NASDAQ:ANPC)
Historical Stock Chart
From Mar 2024 to Apr 2024
AnPac Bio Medical Science (NASDAQ:ANPC)
Historical Stock Chart
From Apr 2023 to Apr 2024